Quotes Cerevel Therapeutics Holdings, Inc.
Stocks
CERE
US15678U1280
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.96 USD | +0.74% |
|
-.--% | - |
Performance
| 1 day | +0.74% | ||
| 3 years | +48.87% | ||
| 5 years | +91.40% |
Volumes
marketsDaily volume
15,096,384
Estimated daily volume
15,096,384
Record volume 1
85,962,450
Record volume 2
31,256,341
Record volume 3
15,096,384
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
8,191,474,701
Net sales ()
-
Number of employees
355
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
93.64 %
Free-Float capitalization (USD)
7,670,416,311
Indicators
Moving average 5 days
44.66
Moving average 100 days
41.9
Price spread / (MMA5)
-0.68%
Price spread / (MMA100)
-6.81%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.74% | -.--% | -.--% | +48.87% | 8.19B | ||
| -4.14% | -8.06% | +58.96% | +118.67% | 54.63B | ||
| +1.84% | -0.66% | +59.82% | +92.96% | 54.88B | ||
| -2.24% | +3.59% | +17.75% | +477.47% | 25.06B | ||
| -1.60% | -6.21% | -18.96% | -15.21% | 23.14B | ||
| +2.43% | +1.06% | +42.44% | -1.27% | 19.88B | ||
| -3.19% | 0.00% | +35.60% | -26.98% | 17.55B | ||
| -6.84% | +2.18% | +195.12% | +357.18% | 16.5B | ||
| -1.05% | +1.16% | +25.95% | +194.27% | 14.2B | ||
| +8.74% | +3.51% | +51.91% | +726.40% | 15.36B | ||
| Average | -0.53% | -0.25% | +46.86% | +197.24% | 24.94B | |
| Weighted average by Cap. | -0.86% | -1.41% | +49.58% | +172.07% |
Historical Quotes: Cerevel Therapeutics Holdings, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 3 years | 19.59 | 44.99 | |
| 5 years | 19.59 | 46.16 | |
| 10 years | 9 | 46.16 |
Monthly variations
Annual variations
| 2024 | +6.04% | ||
| 2023 | +34.43% | ||
| 2022 | -2.71% | ||
| 2021 | +95.54% | ||
| 2020 | +39.33% |
- Stock Market
- Stocks
- CERE Stock
- Quotes Cerevel Therapeutics Holdings, Inc.
Select your edition
All financial news and data tailored to specific country editions
















